Product image of Linezolid Stada (Linezolid) supplied by GNH India

Linezolid Stada

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Stada (Linezolid)

Linezolid, the active ingredient in Linezolid Stada, is an oxazolidinone antibiotic presented as an oral tablet for oral use. It treats serious bacterial infections, including those caused by resistant Gram‑positive organisms, in adult patients.
GNH India supplies Linezolid Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Genus Pharmaceuticals Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibiotic used to treat infections caused by susceptible Gram‑positive bacteria.

  • Skin and soft tissue infections: eradicates Staphylococcus aureus, including MRSA, improving wound healing.
  • Community‑acquired pneumonia: targets Streptococcus pneumoniae and atypical pathogens, reducing respiratory symptoms.
  • Nosocomial pneumonia: effective against hospital‑acquired Gram‑positive pathogens, aiding recovery.
  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: provides an alternative to vancomycin for resistant strains.
  • Vancomycin‑resistant Enterococcus (VRE) infections: offers activity against resistant enterococci when other options are limited.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit, preventing formation of the initiation complex. This action blocks translation, halting bacterial growth and leading to bacteriostatic activity against susceptible Gram‑positive organisms.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools, sometimes watery.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Metallic taste: altered taste perception.
  • Insomnia: difficulty sleeping.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count.
  • Anemia: reduced red blood cell levels.
  • Peripheral neuropathy: tingling or numbness in extremities.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Lactic acidosis: accumulation of lactate causing metabolic disturbance.
  • Optic neuropathy: visual disturbances, potentially irreversible.

Precautions & Warnings

When prescribing Linezolid, clinicians should consider several safety measures.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: assess liver enzymes regularly.
  • Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome.
  • Myelosuppression: perform routine blood counts to detect cytopenias.
  • Pregnancy: safety unknown; weigh potential benefits against risks.
  • Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Linezolid interacts with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): may precipitate serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin toxicity.
  • Rifampicin: induces metabolism, reducing linezolid plasma levels.

Moderate Interactions (Monitor Closely)

  • Warfarin: may increase INR, requiring coagulation monitoring.
  • Phenytoin: may lower linezolid concentrations, affecting efficacy.
  • Antacids containing magnesium or aluminum: can impair absorption, consider timing adjustments.

Frequently Asked Questions

Linezolid Stada is indicated for serious bacterial infections caused by susceptible Gram‑positive organisms, including skin and soft‑tissue infections, community‑acquired and nosocomial pneumonia, as well as infections due to methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE).

Linezolid binds to the 23S rRNA of the bacterial 50S ribosomal subunit, preventing the formation of the initiation complex required for protein synthesis. This inhibition stops bacterial growth, providing a bacteriostatic effect against susceptible Gram‑positive pathogens.

The dosing regimen for Linezolid Stada is determined by the prescribing clinician based on the specific infection, patient characteristics, and local guidelines. Healthcare professionals should follow the recommended dose on the prescription label.

The safety of Linezolid Stada in pregnancy and lactation has not been established. Clinicians should consider the potential benefits against possible risks and discuss options with the patient before initiating therapy.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linezolid offers oral administration and activity against certain resistant Gram‑positive bacteria, such as MRSA and VRE, where vancomycin may be limited to intravenous use. Both agents have distinct safety profiles; linezolid is associated with hematologic effects, while vancomycin carries a risk of nephrotoxicity and ototoxicity.

Linezolid Stada should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain stability.

Linezolid Stada is supplied as an oral tablet and is taken by mouth with or without food, as directed by the prescriber. The tablet should be swallowed whole with an adequate amount of water.

Serious risks include thrombocytopenia, anemia, peripheral neuropathy, serotonin syndrome when combined with serotonergic drugs, lactic acidosis, and optic neuropathy. Patients should be monitored regularly for hematologic changes and neurological symptoms.

Linezolid Stada is contraindicated in patients with known hypersensitivity to linezolid or any component of the formulation. Caution is advised for individuals taking serotonergic agents, those with existing myelosuppression, or patients with uncontrolled hypertension.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.